title: Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients.
abstract: Highly successful bacterial clones have the ability to effectively colonize environmental niches and patients. However, the factors which determine the complex interplay between the colonization of environmental niches and patients are mainly unknown. In this study we show that Pseudomonas aeruginosa clone C strains are distributed worldwide and highly prone to infect cystic fibrosis (CF) patients in Canada, England, France and Germany. In Hanover, Germany and Vancouver, Canada, clone C strains are highly prevalent in the CF patient community, although the mechanisms of acquisition may have been different. All clone C strains showed highly related macrorestriction fragment pattern of the whole genome as visualized by pulsed-field gel electrophoresis and harboured the 102 kbp plasmid pKLC102. Comparison of three prevalent P. aeruginosa clones with different distribution between the environment and patients revealed that neither enhanced biofilm formation nor antibiotic resistance was responsible for the spread of clone C. Clone M, which was highly prevalent in the clinical environment such as sanitary facilities, lacked motility, which could explain its relatively low prevalence in CF patients. Elucidation of the mechanisms which lead to the prevalence of clone C strain in patients and the environment requires the investigation of additional phenotypes.
authors.affiliation: Microbiology and Tumorbiology Center (MTC), Karolinska Institutet, Stockholm, Sweden. Ute.Romling@mtc.ki.se
authors.forename: Ute
authors.initials: U
authors.lastname: Römling
authors.forename: Abdul
authors.initials: A
authors.lastname: Kader
authors.forename: Dinesh Diraviam
authors.initials: DD
authors.lastname: Sriramulu
authors.forename: Roger
authors.initials: R
authors.lastname: Simm
authors.forename: Göran
authors.initials: G
authors.lastname: Kronvall
mesh_terms: D018441:Biofilms; D002170:Canada / Q000453:epidemiology; D003550:Cystic Fibrosis / Q000453:epidemiology* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005060:Europe / Q000453:epidemiology; D036781:Fimbriae Proteins / Q000235:genetics; D005408:Flagellin / Q000235:genetics; D006801:Humans; D009068:Movement; D015995:Prevalence; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology; D014871:Water Microbiology
chemical_list: D005408:Flagellin; D036781:Fimbriae Proteins